基于证据的非侵入性手术前评估对耐药性患者
Eugen Trinka1,2,3,4, Matthias Koepp5,6, Gudrun Kalss1,2
1Department of Neurology, Neurocritical Care, and Neurorehabilitation, Christian-Doppler University Hospital, Paracelsus Medical University, Centre for Cognitive Neuroscience, Member of EpiCARE.
Current opinion in neurology
|February 9, 2024
概括
对耐药焦点的术前评估显著改善了控制和生活质量. 本综述考察了手术前手术评估的诊断准确性和益处.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 诊断成像 诊断成像 诊断成像
背景情况:
- 手术为许多耐药焦点患者提供了无发作和改善生活质量的机会.
- 目前的术前评估是一个复杂的,多学科的过程.
- 对于手术前评估和手术,国际指导方针有限.
研究的目的:
- 审查目前的实践和证据,以确定手术前评估的诊断准确性.
- 评估手术前评估对手术的好处.
主要方法:
- 系统性审查和元分析检查了各种成像和监测技术的诊断准确性.
- 审查了手术前评估和随后手术的益处的证据.
主要成果:
- 视频电脑电图 (EEG) 监测,MRI,电磁源成像和功能性MRI都有可用的诊断准确性数据.
- 很大一部分患者在手术后实现了无性发作,而另一些患者则经历了改善的生活质量和社会融合.
结论:
- 术前评估对于成功的手术结果至关重要.
- 需要进一步制定基于证据的国际指导方针,以标准化术前评估实践.
相关概念视频
Arteries of the Lower Limbs
190
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
190
Antiepileptic Drugs: Potassium Channel Activators
183
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
183


